Neuphoria Therapeutics (NEUP) Current Leases (2020 - 2025)
Historic Current Leases for Neuphoria Therapeutics (NEUP) over the last 5 years, with Q3 2025 value amounting to $85210.0.
- Neuphoria Therapeutics' Current Leases fell 3439.38% to $85210.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $85210.0, marking a year-over-year decrease of 3439.38%. This contributed to the annual value of $116314.0 for FY2025, which is N/A changed from last year.
- Neuphoria Therapeutics' Current Leases amounted to $85210.0 in Q3 2025, which was down 3439.38% from $116314.0 recorded in Q2 2025.
- Neuphoria Therapeutics' 5-year Current Leases high stood at $129881.0 for Q3 2024, and its period low was $85210.0 during Q3 2025.
- Over the past 4 years, Neuphoria Therapeutics' median Current Leases value was $116314.0 (recorded in 2025), while the average stood at $114445.5.
- In the last 5 years, Neuphoria Therapeutics' Current Leases rose by 19.21% in 2023 and then plummeted by 3439.38% in 2025.
- Neuphoria Therapeutics' Current Leases (Quarter) stood at $114631.6 in 2022, then rose by 0.19% to $114851.7 in 2023, then increased by 3.17% to $118492.0 in 2024, then fell by 28.09% to $85210.0 in 2025.
- Its Current Leases was $85210.0 in Q3 2025, compared to $116314.0 in Q2 2025 and $121738.0 in Q1 2025.